Statement Of Cash Flows [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166256

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations
12,812,000 EUR
11,253,000 EUR
Interest paid, classified as operating activities
7,000 EUR
3,000 EUR
Income taxes paid (refund), classified as operating activities
349,000 EUR
Cash flows from (used in) operating activities
13,154,000 EUR
11,250,000 EUR
Cash flows from (used in) investing activities [abstract]
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities
500,000 EUR
21,000 EUR
Other cash payments to acquire interests in joint ventures, classified as investing activities
1,270,000 EUR
Purchase of property, plant and equipment, classified as investing activities
101,000 EUR
107,000 EUR
Proceeds from sales of intangible assets, classified as investing activities
219,000 EUR
Purchase of intangible assets, classified as investing activities
638,000 EUR
954,000 EUR
Cash advances and loans made to other parties, classified as investing activities
1,157,000 EUR
Cash receipts from repayment of advances and loans made to other parties, classified as investing activities
216,000 EUR
Cash flows from (used in) investing activities
1,239,000 EUR
3,075,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
14,337,000 EUR
Proceeds from issuing other equity instruments
2,832,000 EUR
Repayments of borrowings, classified as financing activities
62,000 EUR
Payments of lease liabilities, classified as financing activities
79,000 EUR
Interest paid, classified as financing activities
1,877,000 EUR
Cash flows from (used in) financing activities
7,838,000 EUR
62,000 EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
6,555,000 EUR
14,387,000 EUR
Cash and cash equivalents
43,457,000 EUR
50,012,000 EUR
64,399,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.